Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a narrower loss for the third quarter of 2022. The company’s revenues dropped 9% year-over-year during the quarter.
The Canada-based medical marijuana company reported an adjusted EBITDA loss of C$12.3 million for the third quarter, compared to a loss of C$20.9 million in the prior-year quarter. Total revenues decreased 9% annually to C$50.4 million. Medical marijuana sales increased 8%, while consumer marijuana sales declined 43%.
“We continue to steer our differentiated global cannabis business towards long-term shareholder value creation. This is being accomplished through a sole focus on the most profitable growth opportunities, rationalization of our Canadian cost structure, and disciplined use of capital. Our plan is working and we remain firmly on track to achieving a positive Adjusted EBITDA run rate by the first half of fiscal 2023., ” said Miguel Martin, chief executive officer of Aurora Cannabis.
Shares of Aurora Cannabis traded slightly higher early Friday on the Nasdaq stock market, after closing the previous session higher. It has lost about 58% since the beginning of the year.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Entertainment behemoth The Walt Disney Company (NYSE: DIS) on Wednesday reported higher revenues and earnings for the third quarter of 2022. The results also topped expectations. Third-quarter revenues of the Los
Take-Two Interactive Software (TTWO): A look at the headwinds and tailwinds ahead of this gaming company
Shares of Take-Two Interactive Software Inc. (NASDAQ: TTWO) were up over 2% on Wednesday. The stock has dropped 30% year-to-date but has gained 17% over the past three months. The
The pandemic came as a setback for Lyft, Inc. (NASDAQ: LYFT) as the ridesharing platform was going through a crucial phase when the travel restrictions were imposed. But the company